Summit Trail Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Sell
9,965
-2,235
-18% -$464K 0.03% 504
2026
Q1
$2.58M Buy
12,200
+4,247
+53% +$915K 0.04% 381
2025
Q4
$1.63M Sell
7,953
-6,744
-46% -$1.27M 0.03% 531
2025
Q3
$2.31M Buy
14,697
+10,639
+262% +$1.64M 0.03% 375
2025
Q2
$682K Buy
4,058
+1,397
+52% +$207K 0.01% 611
2025
Q1
$367K Buy
2,661
+489
+23% +$62.3K 0.01% 288
2024
Q4
$257K Sell
2,172
-1,818
-46% -$212K 0.01% 323
2024
Q3
$441K Buy
3,990
+1,373
+52% +$144K 0.01% 426
2024
Q2
$257K Buy
2,617
+247
+10% +$25.2K 0.01% 525
2024
Q1
$266K Sell
2,370
-41
-2% -$4.42K 0.01% 496
2023
Q4
$244K Sell
2,411
-112
-4% -$11.1K 0.01% 448
2023
Q3
$219K Buy
2,523
+211
+9% +$19.1K 0.01% 480
2023
Q2
$220K Buy
+2,312
New +$195K 0.01% 462
2018
Q1
Sell
-843
Closed -$61K 615
2017
Q4
$61K Buy
+843
New +$52.1K 0.01% 768

Other funds holding CAH

Summit Trail Advisors's CAH Position: Q2 2026 in Review

Summit Trail Advisors reduced its Cardinal Health (CAH) stake by 18% in Q2 2026, selling an estimated $464K and leaving 9,965 shares worth $2.37M. The position accounts for 0.03% of the portfolio, ranked #504.

Summit Trail Advisors first reported a position in CAH in Q4 2017 and has held it in 14 quarters since. The position peaked at $2.58M in Q1 2026. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Summit Trail Advisors held 9,965 shares of Cardinal Health worth $2.37M as of Q2 2026.
  • Summit Trail Advisors sold 2,235 Cardinal Health shares in Q2 2026, an estimated $464K.
  • Cardinal Health made up 0.03% of Summit Trail Advisors's portfolio in Q2 2026, its #504 holding.
  • Summit Trail Advisors first reported a position in Cardinal Health in Q4 2017 and has held it in 14 quarters since.
  • Summit Trail Advisors's Cardinal Health position peaked at $2.58M in Q1 2026.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.